Cassava Gears Up to Report Q4 Earnings: What's in the Cards?
On SAVA's fourth-quarter 2024 earnings call, investors can expect updates regarding the company's pipeline developmental plans amid recent setbacks.
Wyoming News20h
Book review: 'Doctored' investigates twists and turns of Alzheimer's drug scandal
Take two at bedtime.
The Daily News2d
'Doctored' is the twists and turns of true story about trying to cure Alzheimer's
If preliminary results were correct, simufilam could be the long-sought-after cure for dementia, the Holy Grail of ...